BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28017968)

  • 21. The γ-secretase inhibitor PF-03084014 combined with fludarabine antagonizes migration, invasion and angiogenesis in NOTCH1-mutated CLL cells.
    López-Guerra M; Xargay-Torrent S; Rosich L; Montraveta A; Roldán J; Matas-Céspedes A; Villamor N; Aymerich M; López-Otín C; Pérez-Galán P; Roué G; Campo E; Colomer D
    Leukemia; 2015 Jan; 29(1):96-106. PubMed ID: 24781018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome.
    Villamor N; Conde L; Martínez-Trillos A; Cazorla M; Navarro A; Beà S; López C; Colomer D; Pinyol M; Aymerich M; Rozman M; Abrisqueta P; Baumann T; Delgado J; Giné E; González-Díaz M; Hernández JM; Colado E; Payer AR; Rayon C; Navarro B; José Terol M; Bosch F; Quesada V; Puente XS; López-Otín C; Jares P; Pereira A; Campo E; López-Guillermo A
    Leukemia; 2013 Apr; 27(5):1100-6. PubMed ID: 23295735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CAD204520 Targets
    Pagliaro L; Cerretani E; Vento F; Montanaro A; Moron Dalla Tor L; Simoncini E; Giaimo M; Gherli A; Zamponi R; Tartaglione I; Lorusso B; Scita M; Russo F; Sammarelli G; Todaro G; Silini EM; Rigolin GM; Quaini F; Cuneo A; Roti G
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255842
    [No Abstract]   [Full Text] [Related]  

  • 24. Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells.
    López-Guerra M; Xargay-Torrent S; Fuentes P; Roldán J; González-Farré B; Rosich L; Silkenstedt E; García-León MJ; Lee-Vergés E; Giménez N; Giró A; Aymerich M; Villamor N; Delgado J; López-Guillermo A; Puente XS; Campo E; Toribio ML; Colomer D
    Oncogene; 2020 Feb; 39(6):1185-1197. PubMed ID: 31616059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of NOTCH1 c.7541_7542delCT mutation in chronic lymphocytic leukemia using conventional and real-time polymerase chain reaction.
    Bilous NI; Abramenko IV; Chumak AA; Dyagil IS; Martіna ZV
    Exp Oncol; 2016 Jun; 38(2):112-6. PubMed ID: 27356580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrasensitive Detection of NOTCH1 c.7544_7545delCT Mutations in Chronic Lymphocytic Leukemia by Droplet Digital PCR Reveals High Frequency of Subclonal Mutations and Predicts Clinical Outcome in Cases with Trisomy 12.
    Hoofd C; Huang SJ; Gusscott S; Lam S; Wong R; Johnston A; Ben-Neriah S; Steidl C; Scott DW; Bruyere H; Gillan TL; Toze CL; Gerrie AS; Weng AP
    J Mol Diagn; 2020 Apr; 22(4):571-578. PubMed ID: 32036086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment.
    Bo MD; Del Principe MI; Pozzo F; Ragusa D; Bulian P; Rossi D; Capelli G; Rossi FM; Niscola P; Buccisano F; Bomben R; Zucchetto A; Maurillo L; de Fabritiis P; Amadori S; Gaidano G; Gattei V; Del Poeta G
    Ann Hematol; 2014 Oct; 93(10):1765-74. PubMed ID: 24923451
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Pozzo F; Bittolo T; Tissino E; Vit F; Vendramini E; Laurenti L; D'Arena G; Olivieri J; Pozzato G; Zaja F; Chiarenza A; Di Raimondo F; Zucchetto A; Bomben R; Rossi FM; Del Poeta G; Dal Bo M; Gattei V
    Haematologica; 2021 Dec; 106(12):3125-3135. PubMed ID: 33121237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fragment analysis represents a suitable approach for the detection of hotspot c.7541_7542delCT NOTCH1 mutation in chronic lymphocytic leukemia.
    Vavrova E; Kantorova B; Vonkova B; Kabathova J; Skuhrova-Francova H; Diviskova E; Letocha O; Kotaskova J; Brychtova Y; Doubek M; Mayer J; Pospisilova S
    Leuk Res; 2017 Sep; 60():145-150. PubMed ID: 28837890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-resolution melting analysis for rapid and sensitive NOTCH1 screening in chronic lymphocytic leukemia.
    Xu JJ; Yao FR; Jiang M; Zhang YT; Guo F
    Int J Mol Med; 2017 Feb; 39(2):415-422. PubMed ID: 28075457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.
    Rodríguez-Vicente AE; Díaz MG; Hernández-Rivas JM
    Cancer Genet; 2013 Mar; 206(3):49-62. PubMed ID: 23531595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL.
    Sportoletti P; Baldoni S; Cavalli L; Del Papa B; Bonifacio E; Ciurnelli R; Bell AS; Di Tommaso A; Rosati E; Crescenzi B; Mecucci C; Screpanti I; Marconi P; Martelli MF; Di Ianni M; Falzetti F
    Br J Haematol; 2010 Nov; 151(4):404-6. PubMed ID: 20813007
    [No Abstract]   [Full Text] [Related]  

  • 33. Decreased expression of dual specificity phosphatase 22 in colorectal cancer and its potential prognostic relevance for stage IV CRC patients.
    Yu D; Li Z; Gan M; Zhang H; Yin X; Tang S; Wan L; Tian Y; Zhang S; Zhu Y; Lai M; Zhang D
    Tumour Biol; 2015 Nov; 36(11):8531-5. PubMed ID: 26032091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of c-Myc-dependent heterogeneous nuclear ribonucleoprotein A1 promotes proliferation and inhibits apoptosis in NOTCH1-mutated chronic lymphocytic leukemia cells.
    Zou Y; Tang H; Miao Y; Zhu H; Wang L; Fan L; Fu J; Xu W; Li J; Xia Y
    Chin Med J (Engl); 2022 Apr; 135(8):920-929. PubMed ID: 35730371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MED12 mutations and NOTCH signalling in chronic lymphocytic leukaemia.
    Wu B; Słabicki M; Sellner L; Dietrich S; Liu X; Jethwa A; Hüllein J; Walther T; Wagner L; Huang Z; Zapatka M; Zenz T
    Br J Haematol; 2017 Nov; 179(3):421-429. PubMed ID: 28771672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotactic Cues for NOTCH1-Dependent Leukemia.
    Piovan E; Tosello V; Amadori A; Zanovello P
    Front Immunol; 2018; 9():633. PubMed ID: 29666622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 14q deletions are associated with trisomy 12, NOTCH1 mutations and unmutated IGHV genes in chronic lymphocytic leukemia and small lymphocytic lymphoma.
    Cosson A; Chapiro E; Belhouachi N; Cung HA; Keren B; Damm F; Algrin C; Lefebvre C; Fert-Ferrer S; Luquet I; Gachard N; Mugneret F; Terre C; Collonge-Rame MA; Michaux L; Rafdord-Weiss I; Talmant P; Veronese L; Nadal N; Struski S; Barin C; Helias C; Lafage M; Lippert E; Auger N; Eclache V; Roos-Weil D; Leblond V; Settegrana C; Maloum K; Davi F; Merle-Beral H; Lesty C; Nguyen-Khac F;
    Genes Chromosomes Cancer; 2014 Aug; 53(8):657-66. PubMed ID: 24729385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single cell analysis revealed a coexistence of NOTCH1 and TP53 mutations within the same cancer cells in chronic lymphocytic leukaemia patients.
    Kantorova B; Malcikova J; Brazdilova K; Borsky M; Plevova K; Smardova J; Radova L; Tom N; Trbusek M; Diviskova E; Francova HS; Navrkalova V; Doubek M; Brychtova Y; Mayer J; Pospisilova S
    Br J Haematol; 2017 Sep; 178(6):979-982. PubMed ID: 27470445
    [No Abstract]   [Full Text] [Related]  

  • 39. A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation.
    Di Ianni M; Baldoni S; Rosati E; Ciurnelli R; Cavalli L; Martelli MF; Marconi P; Screpanti I; Falzetti F
    Br J Haematol; 2009 Sep; 146(6):689-91. PubMed ID: 19604236
    [No Abstract]   [Full Text] [Related]  

  • 40. Overexpression of progelatinase B/proMMP-9 affects migration regulatory pathways and impairs chronic lymphocytic leukemia cell homing to bone marrow and spleen.
    Bailón E; Ugarte-Berzal E; Amigo-Jiménez I; Van den Steen P; Opdenakker G; García-Marco JA; García-Pardo A
    J Leukoc Biol; 2014 Aug; 96(2):185-99. PubMed ID: 25080557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.